Skip to main content

Paxlovid coronavirus medicine

On this page, you can assess whether you belong to any of the groups eligible for the Paxlovid treatment started by the treatment units in specialized medical care at HUS and what you have to do to receive the medicine.

The Ministry of Social Affairs and Health has determined the extended target groups for the new coronavirus medicine Paxlovid. On this page, we provide instructions on how to begin the treatment for those groups of patients who are monitored in specialized medical care at HUS and receive Paxlovid through the treatment units. The medicine can be given to certain cancer patients and to patients who are immunocompromised because of their illness or medication. Our treatment units will also inform these patient groups independently about the possibility to start Paxlovid treatment.

What is Paxlovid? 

Paxlovid is a coronavirus medicine used in outpatient treatment for people aged 18 or over and at risk of developing the severe form of COVID-19 due to illness, immunosuppressive medication or age. The medicine is taken orally. Paxlovid prevents the coronavirus from replicating in the body of the infected person. The active substances in Paxlovid are nirmatrelvir (on the package: PF-07321332) and ritonavir.  

The medication should be started as soon as possible after the onset of symptoms and within 5 days at the latest. Paxlovid interacts with different drugs. Before starting the treatment, your other medication must be checked to exclude an interaction. The duration of the treatment is 5 days. Paxlovid is offered to you free of charge.

You may receive the medicine from a treatment unit in specialized medical care at HUS if 

  • you are aged 18 or over and 
  • you have a coronavirus infection that has been diagnosed in a PCR or antigen coronavirus test conducted in a laboratory (book a time for the test in the koronabotti.hus.fi service) and  
  • any symptom or symptoms of the coronavirus disease (check the symptoms here) and  
  • you belong to one of the groups listed below and are being monitored in these treatment units because of your illness

You cannot get the medicine if

  • you are under 18 years old 
  • you are pregnant (Note! Breastfeeding does not prevent you from getting the medicine, but you must discontinue breastfeeding for the duration of the treatment and for an additional 7 days after taking the last tablet.) 
  • you are hypersensitive to the active substances or the excipients (you will find the product label here
  • you have severe hepatic insufficiency (such as Child-Pugh Class C) 
  • you have severe renal insufficiency (eGFR below 30ml/min), also includes dialysis patients 
  • you take a medicine that interacts with the drug ingredients of Paxlovid (drug interaction).  

Target groups for the medication among certain patients monitored in specialized medical care at HUS

1. Severe immune system disorders and cancer patients

You must be aged 18 or over. You vaccination background does not affect starting the medication.





2. Pulmonary diseases



3. Immunosuppressive medication for an autoimmune disease

You must be aged 40 or over. Unvaccinated persons and those who have received one vaccination dose are eligible to have the medication.




How to get the medicine from your treatment unit

You must meet all of the above-mentioned criteria for the target group of the medication so that it will be possible to assess whether the medication can be started. The medication should be started as soon as possible after the onset of symptoms and within 5 days from their onset at the latest.








Paxlovid cannot be prescribed by private clinics and the medicine is not available on prescription in private pharmacies.

The target groups mentioned on this page also cannot receive the medication from health centers.

 

Feedback

Did you find what you were looking for?